Home » ADVANCIS PHARMA STILL EXPECTS TO LAUNCH KEFLEX IN JULY
ADVANCIS PHARMA STILL EXPECTS TO LAUNCH KEFLEX IN JULY
Advancis Pharmaceutical Corp. announced that the U.S. Food and Drug Administration has informed that its review of the supplemental New Drug Application for additional Keflex, or cephalexin capsules, USP, products is still ongoing.
Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/229035/)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May